Dexcom chosen as first participant in FDA TEMPO pilot to develop AI glucose platform using G7 and Stelo sensors
https://finviz.com/stock?t=DXCM&p=d
Note: Only a member of this blog may post a comment.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.